OMDA · Omada Health, Inc. · Insider Trading

Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $20.11 to $20.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

100% of the shares subject to the option are fully vested and exercisable.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

100% of the shares subject to the option are fully vested and exercisable.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $22.41 to $22.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $21.38 to $22.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

This transaction was executed in multiple trades at prices ranging from $21.38 to $22.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $21.38 to $22.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

This transaction was executed in multiple trades at prices ranging from $22.41 to $22.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $22.41 to $22.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $22.69 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

100% of the shares subject to the option are fully vested and exercisable.

100% of the shares subject to the option are fully vested and exercisable.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $23.75 to $24.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

100% of the shares subject to the option are fully vested and exercisable.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $23.76 to $24.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $22.71 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

100% of the shares subject to the option are fully vested and exercisable.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This Form 4/A is being filed solely to correct the number of shares reported as sold pursuant to the Reporting Person's 10b5-1 plan on August 12, 2026. The amount of shares sold has been adjusted to reflect the addition of 552 shares that were inadvertently omitted from the original Form 4 filed with the U.S. Securities and Exchange Commission on August 12, 2026. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 remains accurate.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

100% of the shares subject to the option are fully vested and exercisable.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

This transaction was executed in multiple trades at prices ranging from $24.70 to $25.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

100% of the shares subject to the option are fully vested and exercisable.